R&D SERVICES/CRO

Novel Validated Approach Monitoring Infant Growth Home Clinical Trials

R&D SERVICES/CRO

SPRIM PRO Announces a Novel and Validated Approach for Monitoring Infant Growth from Home in Clinical Trials, Reducing Burdens on Caregivers and Clinical Sites
September 24, 2024

September 24, 2024, SPRIM PRO – SPRIM PRO, a CRO renowned for its innovative approach...

Sprim Global Investments Names Susan Dallabrida As Chief Executive Officer Of Sprim Consultancy

R&D SERVICES/CRO

SPRIM Global Investments names Susan Dallabrida as Chief Executive Officer of SPRIM Consultancy
February 8, 2022

SPRIM Global Investments announces the promotion of Susan Dallabrida, PhD, to Chief Executive Officer of...

Leveraging Next Gen Tools In Rare Disease Research

R&D SERVICES/CRO

Leveraging Next-Gen Tools in Rare Disease Research
March 1, 2021

The capture of high-quality, accurate and complete datasets in a clinical trial is always of...

Sprim Partners With Health Catalyst To Analyze Covid 19 Impact On Nash And Nafld

R&D SERVICES/CRO

SPRIM Partners with Health Catalyst to Analyze COVID-19 Impact on NASH and NAFLD
June 8, 2020

SPRIM and Health Catalyst partner to jumpstart understanding of COVID-19 impact on NASH and NAFLD...

This site uses cookies to offer you a better browsing experience. By browsing this website, you agree to our use of cookies.
Accept